Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results from a multicenter observational registry
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results from a multicenter observational registry
Authors
Keywords
-
Journal
ENDOCRINE JOURNAL
Volume 61, Issue 12, Pages 1171-1180
Publisher
Japan Endocrine Society
Online
2014-09-11
DOI
10.1507/endocrj.ej14-0211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
- (2014) Noriko Kimura et al. ENDOCRINE-RELATED CANCER
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
- (2014) HYPERTENSION RESEARCH
- Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
- (2013) Hiroshi Wakabayashi et al. ANNALS OF NUCLEAR MEDICINE
- 131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis
- (2013) L. T. van Hulsteijn et al. CLINICAL ENDOCRINOLOGY
- Advances in Anticancer Radiopharmaceuticals
- (2013) M.R. Jackson et al. CLINICAL ONCOLOGY
- Long-Term Outcome and Toxicity After Dose-Intensified Treatment with 131I-MIBG for Advanced Metastatic Carcinoid Tumors
- (2013) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Combination Chemotherapy with Cyclophosphamide, Vincristine, and Dacarbazine in Patients with Malignant Pheochromocytoma and Paraganglioma
- (2013) Akiyo Tanabe et al. Hormones & Cancer
- Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma
- (2011) Daiki Kayano et al. NUCLEAR MEDICINE COMMUNICATIONS
- Endocrine Hypertension: Then and Now
- (2010) William Young Endocrine Practice
- 131I-Metaiodobenzylguanidine Therapy of Neuroblastoma and Other Neuroendocrine Tumors
- (2010) Frank Grünwald et al. SEMINARS IN NUCLEAR MEDICINE
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of the efficacy and toxicity of 131I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
- (2008) A C Nwosu et al. BRITISH JOURNAL OF CANCER
- Takotsubo Cardiomyopathy
- (2008) Yoshihiro J. Akashi et al. CIRCULATION
- EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
- (2008) Francesco Giammarile et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guidelines for radioiodine therapy of differentiated thyroid cancer
- (2008) M. Luster et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pheochromocytoma: Current Approaches and Future Directions
- (2008) J. T. Adler et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now